NCT01067287: Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation |
|
|
| Active, not recruiting | 2 | 35 | US, RoW | CT-011, Dendritic Cell Fusion Vaccine | Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Rambam Health Care Campus, Gateway for Cancer Research, United States Department of Defense | Multiple Myeloma | 09/24 | 12/24 | | |
